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Abstract 
To date malaria is the most important tropical disease, which is caused by Plasmodium sp. and 
vectored by anopheline mosquitoes.  The mosquito’s immune system is one of the limiting 
factors of malaria transmission.  Immune reactions, such as the prophenoloxidase (PPO) pathway 
result in the melanization of pathogens, and are effective at limiting parasite numbers.  Novel 
strategies for malaria control aim to exploit the immune system to interrupt parasite transmission 
by boosting the immune responses in the mosquito vector.  
Serpins play a crucial role in regulating protease cascades involved in immunity of 
arthropods.  In Anopheles gambiae, the major malaria vector in Sub-Saharan Africa, 18 SRPN 
genes encoding 23 distinct proteins have been identified. So far, two are identified as active 
inhibitors, and both affect parasite survival. This research aims to identify additional inhibitory 
serpins in An. gambiae and elucidate their potential function.  Identification of such serpins will 
enhance our understanding of the immune system of this important vector species and may 
identify immunoregulators to be used in malaria control. 
SRPN7, 9, and 18 were tested for their ability to inhibit commercial proteases in vitro.  
Recombinant SRPN18 had no inhibitory activity, while SRPN7 and 9 inhibited several serine 
proteases.  SRPN7, 9 and 18 were tested against two recombinant An. gambiae clip serine 
proteases (CLIPBs) that are required for activation of phenoloxidase and thus regulate 
melanization.  Only SRPN9 strongly inhibited CLIPB9 in vitro, suggesting that this serpin is a 
potential negative regulator of melanization.  This hypothesis is further supported by the finding 
that SRPN9 can inhibit PO activity in insect hemolymph, ex vivo.   
  
Taken together, this research identifies SRPN18 as the first non-inhibitory serpin 
described in mosquitoes.  Additionally, this study describes the larval-specific SRPN7 as a 
functional inhibitor.  Future studies on these proteins will elucidate their precise physiological 
functions.  Finally, this thesis provides strong evidence that SRPN9 is a negative regulator of 
melanization in An. gambiae and may therefore affect pathogen survival within this important 
vector species. 
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Chapter 1 - Introduction 
List of Abbreviations                                                                  
EIP- Extrinsic incubation period                                PAP- Prophenoloxidase activating protease 
LLIN- Long lasting insecticide treated nets               SRPN- Serine Protease inhibitor  
IRS- Indoor residual spraying                                     CLIP-SP- Clip domain serine protease 
PPO- Prophenoloxidase                                               AMP- Antimicrobial peptides 
PO- Phenoloxidase                                                      MS- Mass Spectrometry 
                              SPH- Serine Protease Homologue  
 1.1 Malaria 
 
Malaria is a devastating disease that in 2010 alone killed 660,000 people. The largest numbers of 
these deaths are in Africa and mostly children under five (WHO 2012).  It is especially a 
problem in Sub-Saharan Africa where high mortality rates are seen.  Malaria parasites, including 
Plasmodium falciparum, the most lethal human parasite, are transmitted via female Anopheles 
mosquitoes (Ross, 1899). To date, vector control methods rely primarily on long-lasting 
insecticide treated bednets (LLIN) and indoor residual spraying (IRS) (Fig 1.1). Currently, there 
are no effective sterilizing vaccines available and larval insecticide targets are difficult to utilize 
because female Anopheline mosquitoes may lay their eggs in small pools of water (i.e. 
hoofmarks and old tires filled with rainwater). Coupled with increasing insecticide resistance, it 
is crucial that novel malarial control methods are implemented to control this disease.  The 
Malaria Eradication Research Agenda (malERA) has acknowledged the need for new vector 
control strategies aimed at preventing completion of Plasmodium sp. lifecycle within the vector 
(Control, 2011).   
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Since its discovery in 1880 by Charles Laveran (Laveran, 1982), research has continued to 
uncover facts about the human malaria parasite.  There a five main malarial Plasmodium sp. 
species infecting humans, P. falciparum. P. vivax, P. ovale, P. malariae and P. knowlesi 
(Oddoux et al., 2011).  To be infective, each of these must fulfill a complex life cycle in both the 
definitive as well as intermediate hosts.  
The definitive host is defined as the organism in which parasitic sexual maturity is reached.  In 
Plasmodium sp., the definitive host is the mosquito, which also acts as a vector to human 
populations.  Some mosquitoes are anthropophagic and preferentially bite certain mammals.  For 
example, An. gambiae and Anopheles dirus, malaria vectors of Africa and Southeast Asia, 
respectively, are anthropophagic.   
The lifecycle of the malaria parasite is complex. A female mosquito takes a blood meal from an 
infected individual and ingests gametocytes. In the lumen of the midgut the gametocytes then 
develop into male and female gametes.  The gametes are fertilized and form zygotes, which 
develop into motile ookinetes that breach the peritrophic matrix and midgut epithelia cells 
approximately one day after ingestion of infective blood meal (Fig 1.2). This breaching of the 
midgut is a major immune stimulating event causing midgut epithelial cells to slough off in what 
is described in a “time bomb” model (Han et al., 2000).   The immune response mounted by the 
mosquito significantly decreases parasitic load.  Proteins which are present in the mosquito 
hemolymph may cause parasite encapsulation and lysis.  Ookinetes that survive the immune 
response continue to develop into young then mature oocyts, which undergo sporogony. 
Sporogony results in the production of sporozoites and ultimately leads to the release of 
thousands of sporozoites into the mosquito hemocoel. They then travel to the salivary glands 
where they penetrate a second epithelial layer.  From there, they are mixed with saliva and can 
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be transmitted to their human hosts for completion of the lifecycle.   After ingestion of infective 
blood meal it takes approximately two weeks until the female mosquito can infect an individual. 
The time between the mosquito infections to the point where they are infectious is called the 
extrinsic incubation period (EIP) and depends on the successful completion of the lifecycle 
within the mosquito (Baton and Ranford-Cartwright, 2005; Vlachou et al., 2006). 
 
 1.2. Current and novel malaria control strategies 
 
Competent Plasmodium sp. vectors can be found throughout the world but it is clear that An. 
gambiae is by far the greatest threat to human population as this species cohabitates with humans 
in the highest transmission regions (Fig 1.3).  Current vector control strategies rely mainly on the 
use of chemical insecticides.  DDT, the first chemical insecticide, was introduced in the 1940s 
and was a resounding success decreasing the number of competent vectors (Enayati and 
Hemingway, 2010).   After questions arose about DDT’s long lasting human health and 
ecological effects became a concern, its use was limited (but not abolished) and alternate 
insecticides were pursued.  Since then an effort to use alternate chemicals in IRS and the use of 
LLIN has taken precedence. Currently, these methods are the most successful tools for limiting 
parasite transmission (World Malaria Report, 2012).   IRS, or the spraying of potential mosquito 
resting spots with organophosphates, carbamates, and synthetic pyrethroids is widely effective, 
yet time and cost inefficient. Decreasing the mosquito density, it relies heavily on repeated 
spraying as the average IRS lasts only 4 months (Enayati and Hemingway, 2010). LLIN have 
had major, recent effects on malaria transmission by providing a physical barrier to infectious 
bites as well as exposure of the mosquito to a chemical insecticide.  Currently the WHO has only 
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approved the use of pyrethroids as safe for the use in LLIN.  The push for IRS and LLINs has 
been largely successful.  LLIN alone decreased child mortality by (at least) 14% and reduced the 
number of malaria cases by at least 39% in areas where malaria is stable (Lengeler, 2004). 
Despite this success, the continued use of singular insecticides in bednets will increase the 
selection for resistance in the mosquito populations (Read et al., 2009; Raghavendra et al., 2011).    
The need for novel insecticides has never been higher as resistance to available insecticides 
mount.    
In the last decade, it has been proposed that Late life acting (LLA)  insecticides, that kill the 
mosquitoes after several gonadotrophic cycles, will decrease the selective pressure that current 
insecticides, which kill nearly on contact, are driving (Read et al., 2009).  One such idea is the 
use of entomopathogenic fungus or lower concentrations of current insecticides (permethrin) that 
would kill older less robust mosquitoes (Blanford et al., 2005; Glunt et al., 2011).  Another 
approach utilizes the intracellular endosymbiont Wolbachia. Wolbachia has been recently 
studied as a potential novel vector control agent with reduced fitness costs.  Wolbachia infection 
decreases the lifespan of infected insects and it is also driven into the populations by cytotoxic 
incompatibility (CI) and increased pathogen interference (PI) (Yen and Barr, 1971; Hughes et al., 
2011; Osei-Poku et al., 2012).  Currently, stable Wolbachia infections have been successful in 
insect species such as Aedes aegypti, Culex quinquefasciatus and Drosophila melanogaster; yet 
no stable transgeneration infections been successful in An. gambiae (Hoffmann et al., 2011).  
Additionally, inconsistent results of different Wolbachia strains and their effect on infection of 
different Plasmodium species have recently been published.  An. gambiae somatically infected 
with Wolbachia showed inhibition of Plasmodium falciparum infection, whereas it increased 
infection with the murine parasite, Plasmodium bergei (Hughes et al., 2011; Hughes et al., 2012).  
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Furthermore, chemicals targeting proteins involved in negatively regulating immune responses 
have been proposed.  One such target, is a serine protease inhibitor (SRPN) SRPN2, which 
functions as a negative regulator of the melanization response in An. gambiae.  Knockdown of 
this immunity related protein increases the number of encapsulated parasites as well as decreases 
the mosquito’s life span and is an interesting new insecticide target. (An et al., 2011). 
 
 1.3 Immunity 
 
Mosquitoes are exposed to numerous potentially pathogenic bacteria, virus, parasites and fungi 
that they must defend themselves against.  Because of the close proximity in which they live 
with potential pathogens, and their hematophagous nature, mosquitoes have many routes of 
protection against these microbes.  Defenses such as chitin dense exoskeleton and the 
periotrophic matrix provide physical barriers between pathogen and insect.  If these are 
breached, a host of cellular and humoral responses work to protect the insect.  First, the pathogen 
is recognized and then, typically, an immune signal is amplified by extracellular protease 
cascades.  These cascades may lead to the activation of effector mechanisms such as humoral 
immune cascades i.e. TOLL, melanization, or complement-like TEP mediated killing.  These 
immune pathways are summarized in Fig 1.4. 
1.3.1 Recognition 
Arthropod immunity against parasites and parasitoids (and all pathogens) is initiated upon 
recognition of foreign invaders.  Components of microbes, called microbial associated molecular 
patterns (PAMP) are non-self motifs foreign to the insect such as LPS, β-1,3 glucans and 
peptidoglycans.  PAMPs are recognized by pattern recognition receptors (PRR) such as Gram 
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Negative Binding Protein (GNBP), Peptidoglycan Recognition Proteins (PGRP) and thioester-
containing proteins (TEP).  TEP proteins circulate as soluble hemolymph factors secreted by 
hemocytes, activated by yet unknown mechanisms (Levashina et al., 2001).  Other proteins 
involved in parasite clearance, Leucine-rich repeat proteins (LRIM) LRIM1 and APL1C (Riehle 
et al., 2008) form a hetero-dimeric complex (Povelones et al., 2011).  Interaction between TEP1 
and this hemolymph complex may cause C-terminal domain cleavage and activation of TEP1.  
The exact mechanism behind this is unclear, and the role of LRIM1 and APL1C in different 
mosquito/parasite combinations can vary (Osta et al., 2004; Dong et al., 2006; Riehle et al., 
2006; Mitri et al., 2009).  Ultimately, activated TEP1 binds to invading pathogens (bacteria 
(Levashina et al., 2001) and Plasmodium parasites (Blandin et al., 2004; Povelones et al., 2009)  
after interacting with the APL1C/LRIM1 complex (Fraiture et al., 2009; Povelones et al., 2009). 
TEP proteins increase parasite melanization and lysis(Povelones et al., 2009).   
Toll and immune deficiency (IMD) pathways are arguably the best studied branches of insect 
immunity and culminate in the production of antimicrobial peptides as well as effector proteins.  
The Toll pathway has been most studied in the model organism D. melanogaster where it was 
first described (Hashimoto et al., 1991).   The Toll pathway is activated in response to fungi and 
Gram positive bacteria.  Humoral PRRs such as short (S) secreted PGRP-SA and PGRP-SD 
(Michel et al., 2001; Bischoff et al., 2004) or GNBP-1 (Gobert et al., 2003) bind to 
peptidoglycan on the surface of the bacteria. Activation of another branch of the Toll pathway is 
stimulated when GNBP3 binds β-glucans on fungi (Gottar et al., 2006). Pathogen secreted 
virulence factors can also activate the Toll pathway, which stimulates serine proteases such as 
Persephone (Fullaondo et al., 2011).  This initiates extracellular protease cascades that ultimately 
lead to the cleavage and activation of the Toll ligand, Spätzle (DeLotto and DeLotto, 1998).  
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IMD is similarly activated by a different class of PRRs, membrane bound PGRPLC.  In An. 
gambiae this trans-membrane protein recognizes and binds to peptidoglycan from Gram positive 
and Gram negative bacteria (Meister et al., 2009).  In D. melanogaster this causes formation of a 
large receptor-adaptor complex (Georgel et al., 2001; Leulier et al., 2002).  In An. gambiae this 
complex associates through death domains and cause the proteolytic activation of transcription 
factor, REL2 (Frolet et al., 2006) and antimicrobial peptide and effector molecule synthesis.   
1.3.2 The Toll Pathway 
To date, most functional studies of immunity-related pathways focus on genetic model 
organisms such as D. melanogaster or larger insects, such as M. sexta, which make biochemical 
analysis easier.  Toll is a key component in insect immunity as well as. D. melanogaster 
development where it was first described (Anderson et al., 1985; Lemaitre et al., 1995; Lemaitre 
et al., 1996).  In immunity, it is currently thought that there are three branches of the Toll 
pathway.  These branches are serine protease cascades that propagate the danger signal. 
Circulating as inactive zymogens, these serine proteases sequentially activate downstream 
proteases and converge upon Späptzle processing.  Two PRR pathways are activated by PGRP-
SA and PGRP-SD (Michel et al., 2001; Bischoff et al., 2004) or GNBP-1 (Gobert et al., 2003) in 
response to Gram positive bacteria and fungi (see above). These signals are integrated by a 
modular serine protease ModSP (Buchon et al., 2009), which initiates serine protease cascades. 
The third branch of Toll extracellular cascades is activated by virulence factors (proteases) that 
cleave Toll proteases such as Persephone (Gottar et al., 2006).  Further experiments using RNAi 
identified an additional three serine proteases upstream of Toll ligand activation.  The current 
Toll pathway model for these two branches in D. melanogaster immunity is that ModSp 
organizes messages from the PRRs and activates Grass.  Spirit is then activated downstream and 
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subsequently spätzle processing enzyme (SPE) (Kambris et al., 2006).  SPE cleaves and activates 
the Toll ligand Spätzle (DeLotto and DeLotto, 1998), which binds to and activates the 
transmembrane receptor Toll (Weber et al., 2003).  After Toll activation intracellular proteins 
Tube and Pelle are recruited to the cell membrane (Towb et al., 1998), and MyD88 associates 
with the cytoplasmic side of TOLL (Tauszig-Delamasure et al., 2002) via a TIR domain.  Tube 
and Pelle associate with MyD88 through the formation of death domains forming a 
heterotrimeric complex (Sun et al., 2002). Pelle may then activate kinases, which phosphorylate 
the IĸB homologue Cactus.  Cactus circulates in the cytoplasm as an inhibitory Cactus-
Dorsal/Dif complex.  Its phosphorylation initiates cactus degradation and NF-ĸB/REL family 
transcription factors Dorsal or Dif are translocated into the nucleus. Here, they regulate 
expression of antifungal AMP drosomycin (Lemaitre et al., 1996) as well as other AMPs and 
other effector proteins in the functional equivalent to the mammalian liver, the fat body.  A 
microarray study in 2002 showed that in addition to AMP production, Toll and IMD regulate 
most genes induced by microbial infection (De Gregorio and Lemaitre, 2002).  
The end result of Toll, AMP and effector protein transcription and translation, uses up 
precious resources and energy.  Because of this, the Toll pathway is tightly regulated.  In D. 
melanogaster as well in An. gambiae, serine protease inhibitors (serpins) are key regulators of 
the extracellular Toll cascades.  There have been three serpin genes shown to have immune 
functions in D. melanogaster. Necrotic (Spn43Ac) inhibits the gram positive/fungal arm of Toll, 
likely through Persephone (Levashina et al., 1999; Robertson et al., 2003). Spn1 inhibits a 
trypsin-like serine protease, Grass, upstream in the fungal recognition branch of the Toll pathway 
(Fullaondo et al., 2011).  Spn5 (Spn88Ea) was also shown to regulate Toll, though its location in 
the pathway is unclear (Ahmad et al., 2009).   
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Sequencing of the An. gambiae genome in 2002 (Holt et al., 2002) drastically aided the 
understanding of the An. gambiae immune responses.  A comparative analysis of the known D. 
melanogaster genome to the newly sequenced An. gambiae genome identified 18 gene families, 
containing 242 An. gambiae gene homologous of 185 immunity related genes in D. 
melanogaster (Christophides et al., 2002).  41 clip-domain serine proteases (CLIPs) were 
identified in An. gambiae (compared to 35 in D. melanogaster), and six were up-regulated in 
response to bacterial and/or malaria infection (Christophides et al., 2002).  Low 1:1 orthology of 
CLIP serine proteases between the species exists and there is little functional data indicating 
which proteses are involved in the extracellular cascade. Despite this, it is likely that the 
mosquito extracellular Toll activation cascade is similar to that in D. melanogaster.  
Additionally, 1:1 orthologues of intracellular components of the pathway have been identified 
for MyD88, Tube, Pelle, and Cactus (Christophides et al., 2002).  An. gambiae orthologs to D. 
melanogaster Dorsal, and Rel1 (previously Gambif1) were identified and shown to translocate to 
the nucleus and increase AMP production (Barillas-Mury et al., 1996). Functional data are 
needed to confirm that these genes in An. gambiae are operating as their D. melanogaster 
orthologs. (Fig 1.5) 
1.3.3 The Phenoloxidase Activation Pathway 
Prophenoloxidase (PPO), the inactive zymogen of phenoloxidase (PO) is a large metalloprotein 
enzyme that exisits as a dimer of approximately 160 kDa (Hall et al., 1995) containing 3 copper 
binding sites (Decker et al., 2007). Synthesized in hemocytes, the zymogen enters the 
hemolymph apparently via cell lysis and is either transported to the cuticle where it has an 
unknown function or it is activated in response to pathogens or wound healing (Asano and 
Ashida, 2001).   
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 The phenoloxidase cascade has been studied in detail in large insect species such as B. mori and 
M. sexta where biochemical analysis is much easier due to the large volume of hemolymph 
available from a single insect.  Ultimately leading to melanization (sequestration) of invading 
pathogens, this pathway plays an integral role in arthropod immunity.  Phenoloxidase activity is 
stimulated by injury and/or recognition of pathogen moieties such as β-1-3-glucans and LPS 
(Lee et al., 1998). This stimulates a cascade of CLIP domain serine proteases (CLIPs) which are 
modulated by non-catalytic CLIPs called serine protease homologues (SPH)(Yu et al., 2003).  
CLIPs are serine proteases that have a unique N-terminal paperclip-like domain and a catalytic 
serine protease domain at the C-terminus. These proteases circulate as zymogens until they are 
protolytically activated by cleavage at their linker region found between the CLIP and catalytic 
domains (Jiang and Kanost, 2000).  Activation of terminal CLIPs, known as phenoloxidase 
activating proteases (PAPs) result in the proteolytic cleavage and activation of zymogen 
prophenoloxidase to phenoloxidase and ultimately, melanization.  
Active PO enzyme catalyzes a very complex and multifaceted reaction that results in 
eumelanin synthesis.  PO causes hydroxylation of tyrosine to DOPA and the oxidation of DOPA 
and dopamine to dopaquinone. DOPA and dopaquinones can undergo redox cycling yielding 
semiquinones and quinones.  Additionall enzymatic and non-enzymatic reactions lead to the 
formation of eumelanin (Fig 1.5).  Byproducts of this pathway include toxic free radicals which 
may help in pathogen clearance, but must be strictly regulated by the insect to limit self-damage 
(Nappi et al., 2009).  The melanization pathway is negatively regulated by a family of proteins 
known as serine protease inhibitors, or serpins. 
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1.3.4 Protease Cascades 
Extracellular protease cascades function in a wide range of biological processes from 
development to coagulation and immunity.  In arthropods, most of these are CLIP serine 
proteases (Muta et al., 1990).  The first CLIP identified was proclotting enzyme from the 
horseshoe crab (Tai and Liu, 1977) (Nakamura et al., 1985) (Muta et al., 1990) and was 
described to contain a unique disulfide knotted domain.  Subsequently, a similar domain was 
described in D. melanogaster snake and easter, serine proteases required for dorsal-ventral 
patterning in developing D. melanogaster larvae (DeLotto and Spierer, 1986; Chasan and 
Anderson, 1989; Wichmann et al., 2001).  In insect species that have been studied serine 
protease cascades are responsible for acute phase defenses against infection. Many are secreted 
into the hemolymph, allowing them to be quickly activated to aid in coagulation, wound healing, 
TOLL activation, and pathogen sequestration in the hemoceal of the mosquito(Gorman and 
Paskewitz, 2001). 
 1.3.5 Serpins 
 1.3.5.1 Structure 
In 1980 Hunt and Dayhoff recognized similarity in sequence between antitrypsin, ovalbumin and 
antithrombin and suggested a novel family of proteins (Hunt and Dayhoff, 1980) that were later 
named Serpins, or serine protease inhibitors (Carrell and Owen, 1985). These proteins make up 
a large family of metastable proteins that maintain low sequence similarity but are structurally 
conserved.  Serpins contain 350-400 amino acids and are single domain proteins, made of up to 
three β-sheets which are surrounded by up to 9 α-helices (Huntington, 2011).  The  most 
functionally important region of the protein is the so-called reactive center loop (RCL), which 
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lends specificity and inhibitory efficacy to the molecule.  Located at the C-terminus, the exposed 
RCL sits acts as bait for the target protease. Elongating or shortening the RCL by even 1 amino 
acid can limit inhibitory potential as well as decrease complex stability (Zhou et al., 2001).  
Serpins are known as suicide inhibitors because the serpin as well as the protease are effectively 
irreversibly inhibited.   In 2000, the crystal structure of the first complexed serpin was resolved 
to 2.6Å and verified that after cleavage and formation of an acyl intermediate, a covalent ester 
bond is formed between the P1 of the serpin and the active Ser of the target protease, ultimately 
destroying the protease’s active site.  The RCL completely inserts into β-sheet A and the target 
protease is translocated to the opposite pole of the serpin (Huntington et al., 2000) (Fig. 1.6).  
This insertion allows the serpin to reach its lowest energy state, known as the relaxed state and is 
irreversible (Loebermann et al., 1984). Important regions of the RCL that are essential for 
inhibition are the hinge region and sessile bond denoted P1-P1' (Schechter and Berger, 1967).  
To accommodate the large conformational change, the hinge region is typically made up of small 
amino acids.  Additionally, the P1 amino acid determines the specificity of the inhibitor as its 
identity determines what type of serine protease may cleave it.  A positively charged amino acid 
(such as Arg or Lys) at the P1 position indicates a trypsin-like serine protease target (Olsen et al., 
2004), whereas an aromatic amino acid (such as Phe, Tyr or Trp) indicates chymotrypsin 
specificity (Schellenberger et al., 1991). 
1.3.5.2 Function 
Serpins are the largest family of serine protease inhibitors and are ubiquitously found from 
humans to viruses and plants (Kotwal and Moss, 1989; Brandt et al., 1990).    Theses inhibitors 
have been shown to be involved in a myriad of biological function, yet the best studied serpins 
are involved in hemostasis regulating cascades such as blood coagulation, fibrinolysis, protein C 
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systems and complement activation (Hunt and Dayhoff, 1980; Patston et al., 1991).  
Additionally, some serpins are no longer inhibitory and have evolved to have roles in 
physiological processes such as molecular transport (Thyroxin Binding Globulin) (Flink et al., 
1986), blood pressure (Angiotensinogen) (Doolittle, 1983), and storage (Ovalbumin) (Hunt and 
Dayhoff, 1980). In insects, serpins play similar roles to their mammalian counterparts and have 
been shown to be involved in mating (Wolfner et al., 1997), development (Ligoxygakis et al., 
2003) and extracellular, complement-like innate immune cascades such as Toll (Levashina et al., 
1999) and PPO pathways (De Gregorio et al., 2002; An et al., 2012).   
 1.3.5.3 SRPNs Encoded in An. gambiae Genome 
Presently, in Anopheles, 18 SRPN genes have been identified (Christophides et al., 2002; 
Waterhouse et al., 2007) (Suwanchaichinda and Kanost, 2009).  Alternate splicing of SRPN4 (3 
isoforms) (Suwanchaichinda and Kanost, 2009) and SRPN10 (4 isoforms) (Danielli et al., 2003) 
contributes to a total of 23 distinct SRPN proteins encoded in the An. gambiae genome.  The 
majority of the SRPNs form four clusters on two chromosomes (Christophides et al., 2002) 
(Suwanchaichinda and Kanost, 2009).  There are two clusters on chromosome arm 2L, one 
containing SRPN1, 2, 3 and another encompassing SRPN7, 14, 18.  Clusters on two 
chromosome arms 2R and 3R encode SRPN11, 12, 17 and SRPN5, 6, 16 respectively 
(Suwanchaichinda and Kanost, 2009).   Additionally, An.gambiae SRPNs form phylogenetic 
clusters that may be mirrored by their physiological relatedness where SRPN1, 2, 3 are most 
similar, and SRPNs 6, 4, 5, 16 and 7, 14, 18 cluster together (Michel et al., 2005) 
(Suwanchaichinda and Kanost, 2009) .   These serpins, like in other insect species have variable 
expression under different physiological conditions and tissue tropism.  All are presumed to be 
secreted as they contain a putative signal peptide (Gulley et al., 2013) with the exception of 
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SRPN10, which has been shown to be nucleocytoplasmic in hemocytes and pericardial cells. In 
midgut cells, SRPN10 is nuclear until infection when it is exported to the cytoplasm (Danielli et 
al., 2003). 
1.3.5.4 An. gambiae SRPNs Involved in Immunity  
In An. gambiae, only a few SRPNs have been shown to be involved in immunological processes.  
SRPN10 encodes four different isoforms, of which SRPN10B (KRAL) is most highly expressed 
(Danielli et al., 2003).  Additionally, SRPN10 (KRAL and RCM) expression is increased in 
Plasmodium bergei infected midgut cells and has been proposed as a midgut invasion marker 
(Danielli et al., 2005).  SRPN6 is also expressed in hemocytes. In addition, SRPN6 is expressed 
in the midgut and salivary gland epithelia after human and murine Plasmodium infection. 
Depletion of SRPN6 in An. stephensi increases the number of P. bergei oocysts (Abraham et al., 
2005; Pinto et al., 2008). Additionally, SRPN6 knockdown  in An. gambiae increases the number 
of salivary gland invading parasites (Pinto et al., 2008).  SRPN2 depletion markedly reduced the 
number of successful oocyst numbers in Plasmodium bergei infected mosquitoes due to 
increased lysis/melanization (Michel et al., 2005). However, SRPN2 depletion did not have an 
effect on the human malaria parasite, Plasmodium falciparum (Michel et al., 2006).  Further 
analysis showed that SRPN2 directly inhibited a known PAP, CLIPB9 and double knockdown 
reversed the SRPN2 melanization phenotype (An et al., 2011).  To date, no functional data have 
shown SRPN’s involvement in regulating TOLL in An. gambiae.  This data further substantiates 
the complex nature of serpin’s role in An. gambiae immunity and the need for further functional 
studies. 
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 1.5 Figures Legends 
Figure 1-1: Global map of malaria transmission and use of IRS or LLIN in areas of high 
transmission 
A. Global map of countries with ongoing transmission of malaria.  Areas with persistent 
transmission are tan.  Countries with continued transmission of malaria which have also reported 
cases of resistance to insecticides are brown.  B. Percentage of populations from countries in 
Sub-Saharan Africa that are reporting usage of LLIN and/or IRS.  Countries reporting less than 
25% of the population with protection are colored beige.  Countries in tan report 50-80% of their 
populations have protection against malaria.  Brown colored countries report over 80% coverage 
of their populations using IRS and/or LLIN. Images taken from World Malaria Report 2012. 
 
Figure 1-2: Plasmodium sp. Lifecycle 
The complex life cycle of Plasmodium sp. in its intermediate and definitive hosts.  See text for 
further details.  Image taken from (Su et al., 2007).  
  
Figure1-3: Global map of malaria vectors 
Global map of the dominant or potentially important malaria vectors in regions which malaria is  
or has been endemic.  Dominant vectors were identified by selecting the species that fed most 
frequently and survived the longest.  Image taken from (Kiszewski et al., 2004).   
 
Figure1-4: Overview of An. gambiae immune response  
Graphical representation of the primary immune responses of An. gambiae: Toll, melanization 
and TEP mediated pathogen clearance.  Extracellular protease cascades lead the activation of 
these main immune responses and culminate in the production of (1) AMP, (2) Melanized 
pathogens and (3) TEP mediated pathogen lysis and/or phagocytosis. For detailed description of 
these pathways please see text.  Figure adapted from (Gulley et al., 2013). 
 
 
 
23 
 
Figure1-5: Melanogenesis pathway in insects  
Overview of the phenoloxidase pathway in insects.  This figure shows the synthesis of eumelanin 
as well as alternate byproducts of the pathway, pheomelanin, quinones and free radicles.  The 
figure was taken from (Nappi et al., 2009). Further details in text. 
 
Figure1-6: Serpin suicide inhibition mechanism  
Serpin inhibition mechanism.  Target protease in green approaches and cleaves the bond between 
the  P1-P1' of the RCL.  This initiates a conformation change in which the RCL swings around 
and inserts into β-Sheet A of the serpin.  In this reaction, the protease is dragged to the opposite 
pole of the serpin and is covalently bond to the serpin.  Figure adapted from (Huntington, 2011) 
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 1.6 Figures 
Figure 1-1: Global map of malaria transmission and use of IRS or LLAN in areas of high 
transmission. 
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Figure 1-2: Plasmodium sp. Lifecycle  
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Figure 1-3: Global map of malaria vectors 
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Figure 1-4: Overview of An. gambiae immune response  
 
28 
 
Figure 1-5: Melanogenesis pathway in insects  
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Figure 1-6: Serpin inhibition mechanism  
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Chapter 2 -  Biochemical characterization of SRPN7 and SRPN18 
 2.1 Abstract 
In insects, serine protease inhibitors (Serpins, SRPNs) are involved in numerous physiologic 
events such as development, mating, digestion, clotting and immunity. They are found in all 
tissues and throughout all life stages.  These proteins form covalent complexes with target 
proteases which can be seen using western blot analysis by the appearance of higher weight 
molecular bands.  In Anopheles gambiae, 18 serpin genes encoding 23 distinct proteins have 
been identified; though few have been biochemically characterized and even fewer native targets 
have been identified.  In this study An. gambiae SRPN7 and 18 were characterized 
biochemically.  One, canonical SRPN7, is predicted to be an inhibitory SRPN with trypsin like 
specificity though was not able to inhibit any of the native proteases tested.  Published 
expression data shows that it is most highly expressed in larval and early pupal stages.  This may 
indicate a possible role in development as transcript levels severely decline in late pupae and 
adults (Suwanchaichinda and Kanost, 2009).  Another, SRPN18, which clusters on chromosome 
arm 2L with SRPN7, has been classified as non-inhibitory.  This was confirmed after testing 
against an array of native and commercially available serine proteases.  This study aims to aid to 
the current knowledge of serpin biology in the major malaria vector, An gambiae.  Here, I show 
that SRPN7 is an inhibitory serpin which inhibits trypsin-like proteases.  Additionally, SRPN18 
is the first non-inhibitory serpin described in mosquitoes. 
  2.2 Introduction 
Insects do not have an adaptive arm of their immune system; instead they rely solely on innate 
defenses.  Extracellular protease cascades regulate many immune responses similar to that of the 
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mammalian complement system.  These cascades are largely made up of serine proteases such as 
in the Toll (Levashina et al., 1999; Ahmad et al., 2009; Fullaondo et al., 2011) and 
prophenoloxidase (PO) pathways (Gorman et al., 2007; Wang and Jiang, 2007; An et al., 2011).  
Stimulation of the Toll pathway increases the production of antimicrobial peptides (AMPs) and 
effector proteins (Barillas-Mury et al., 1996; De Gregorio and Lemaitre, 2002).  PO activation 
results in melanization, or encapsulation of pathogens.  If activated, these pathways are energy 
consuming generally culminating in protein production which requires the use of scarce amino 
acids.  Alternately, these pathways can be toxic to the organism itself by mechanisms such as the 
production of toxic quinones in melanization (Nappi et al., 2009).  Because it is costly for the 
organism to maintain these defenses as constitutively “on” many of these proteases are expressed 
at a basal level and circulate throughout the hemolymph in inactive zymogen forms.  Zymogens 
may then be quickly activated upon stimulation.   
In serine proteases the catalytically important residues His57, Ser195 and Asp102, known as the 
catalytic triad (Matthews et al., 1967; Blow et al., 1969) are located in a region known as the 
binding pocket and are responsible for cleaving the target protein.  Serine protease specificity is 
determined by the amino acids that make up the binding pocket.  Elastase-like serine proteases 
(e.g. elastase and Subtilisin Carlsberg) have a binding pocket made up of large side chain 
containing amino acids, and thus prefer to cleave after small neutral amino acids.  Conversely, 
chymotrypsin’s binding pocket is made up of small side chain amino acids and can accommodate 
larger amino acids and prefers to cleave after aromatic amino acids.  Plasmin, kallikrein, 
thrombin and trypsin are trypsin-like serine proteases which tend to cleave after positively 
charged amino acids such as Lys or Arg.  These proteases have a multitude of functions in 
mammals including, but not limited to, blood coagulation, fibrinolysis, protein C systems and 
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complement activation.  They are negatively regulated by a large family of proteins called serine 
protease inhibitors or serpins (Carrell and Owen, 1985).   
Serpins are largely secreted and circulate as metastable proteins.  After cleavage of the sessile 
bond (P1-P1') by a target protease, the serpin undergoes a dramatic conformational change where 
their RCL inserts into the core of the serpin and reaches its lowest energy state.  As this occurs, 
the target proteases’ active site is distorted and becomes covalently linked to the serpin.  Both the 
serpin as well as the protease are irreversibly inhibited and thus they are referred to as suicide 
inhibitors.  Due to the huge conformational change associated with the inhibitory mechanism, 
predictions can be made about serpins based on key regions within the reactive center loop 
(RCL).   
The RCL is a portion of the protein that sits away from the body of the serpin and acts as bait for 
the target protease.  The RCL is integral for the functionality of serpins and inhibitory potential 
can be predicted by analyzing this stretch of amino acids.  The most important region of the RCL 
is the sessile bond denoted P1-P1', which is the bond cleaved by the target protease.  Serpins tend 
to inhibit certain classes of serine proteases (e.g. trypsin-like, chymotrypsin-like or elastase-like), 
and this specificity is determined by the amino acid in the P1 position.  In insects they are 
responsible for many biologically important events from mating to immune regulation (Coleman 
et al., 1995) (Levashina et al., 1999).  Currently, only a few serpins have been shown to be 
involved in regulating immune responses in anophelines.  SRPN6 is expressed in hemocytes and 
salivary glands in An. gambiae and An. stephensis until the insect is stimulated by the murine 
malaria parasite, Plasmodium bergei.  After infection the gene is up-regulated in midgut 
epithelium where it may aid in preventing the parasite from exiting the midgut.  This hypothesis 
is supported as SRPN6 depletion in An. stephensi increases the number of successful oocysts 
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(Abraham et al., 2005).  SRPN10 (KRAL) expression is increased in Plasmodium bergei infected 
midgut cells and has been proposed as a midgut invasion marker (Danielli et al., 2005)  Finally, 
SRPN2 has been characterized as a negative regulator of the PO pathway as it can directly inhibit 
a terminal PO activating protease (PAP), CLIPB9.  Furthurmore, SRPN2 depletion causes the 
spontaneous appearance of melanotic pseudotumors (An et al., 2011). In this study two An. 
gambiae SRPNs have been biochemically characterized, though native targets have not yet been 
identified. 
 2.3 Materials and methods 
2.3.1 Mosquito Rearing 
An. gambiae G3 line was used in these experiments.  Females were allowed to oviposit on wet 
filter paper then floated in water to allow hatching.  For 48 hours larvae were fed on 2% baker’s 
yeast (Red Star, Active Dry Yeast) then switched to 2% w/v fish food (TetraMin Tropical 
Flakes, Tetra) and baker’s yeast 2:1 ratio.  Adult mosquitoes were fed on an 8% fructose + 
2.5mM PABA (Sigma) solution ad libitum, and heparinized horse blood (Plasvacc) was fed 
through an artificial glass feeder using parafilm as a membrane.  All stages were reared at 80% 
humidity, 27ºC and a 12:12 light:dark cycle 
2.3.2 SRPN7 and 18 Cloning  
cDNA fragments encoding the full-length mature proteins were amplified using the gene-specific 
primers listed in Table 2.2. The forward primers included an NcoI site and the reverse primers 
contained an EcoR1 restriction site.  A second round of PCR was performed and the forward 
primers contained six codons for histidine residues.  The reverse primers are the same as round 1 
PCR.  The PCR products were digested with NcoI and EcoR1, and then inserted into the same 
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restriction sites into a pET-28a vector (Novagen).  The plasmids were transformed into BL21 
(DE3) competent E. coli cells and stored at -80º.   
To biochemically characterize SRPN7 and 18, recombinant SRPN18 protein was expressed 
using an Escherichia coli expression system.  The full coding region, minus the predicted signal 
peptide, was amplified using gene specific primers. SRPN18 protein was expressed using BL-21 
DE3 competent E. coli cells.  Cells containing plasmid were grown overnight at 37˚C from 
bacterial stocks on LB agar plates containing 50µg/ml kanamycin.  A single colony was 
inoculated into 250 ml flask containing 50ml LB containing and 50µg/ml Kanamycin then shook 
overnight at 37˚C 150rpm.  15ml of the overnight culture was used to inoculate 2, 2 liter flasks of 
500ml LB with 50µg/ml Kanamycin.  Inoculated culture was incubated at 37.0˚C and shook at 
225rpm for approximately 2 hours to an OD600 between 0.6-0.8.  Protein expression was induced 
using 0.1mM IPTG and incubated at least 8 hours at 20 ˚C, 150rpm.  The culture underwent 
centrifugation 4000rpm 20 minutes and the pellet was kept at -80˚C.  Cloning and purification of 
SRPN7 was performed by Mrs. Tinea Canady. 
2.3.3 Recombinant Protein Purification  
Cell pellets from expression was re-suspended in lysis buffer (300mM NaCl + 10mM imidazole) 
4 ml buffer/gram pellet.  Cells were lysed by sonication (Vibra Cell High Intensity Ultrasonic 
Processor 750 Watt model), and soluble and insoluble fractions were separated by centrifugation 
at 10,000g for 40min at 4.0˚C.  Soluble portions were retained and purified by running the 
sample through a column containing 2 ml Ni-NTA (Qiagen) beads.  Bound proteins were washed 
twice with wash buffer (20ml 300µM NaCl + 20mM imidazole) to remove unbound proteins.  
Bound proteins were eluted in 4, 5ml fractions using elution buffer (300µM NaCl + 250mM 
imidazole).  Salts were removed by dialysis, three times for eight hours in dialysis buffer (20mM 
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Tris + 20mM NaCl, pH = 8.)  The sample was further purified by running the sample through 
column containing 2 ml Q Sepharose Fast Flow beads (GE Healthcare) equilibrated with 20mM 
Tris + 20mM NaCl.  Unbound proteins were removed by 10 ml wash buffer (20mM Tris + 
20mM NaCl).  Protein was eluted off the column by a low to high salt gradient (50-200mM 
NaCl+20mM Tris). Fractions were analyzed by 10% SDS-PAGE and pooled.  Protein 
concentrations were determined by Bradford assay using Comassie Plus Protein Assay Reagent 
(Pierce) and bovine serum albumin as a standard (Sigma). Purification of SRPN7 was done by 
Mrs. Tinea Canady. 
2.3.4 SDS-PAGE electrophoresis and Western Blotting 
Recombinant proteins were denatured with 6X SDS buffer containing β-mercaptoethanol for 5 
minutes at 95 ºC.  The samples were then separated using 10% SDS-PAGE electrophoresis for 
20 min at 100 volts followed by 40 min at 180 volts.  The gel was stained with EZ-Run Protein 
Gel Staining solution (Fisher).  For immunoblot analysis proteins were transferred to PVDF 
membrane (GE Healthcare) at 0.110 Amps for 1 hour.  Membranes were blocked in 5% skim 
milk for 1 hour and washed 3 times for 10 minutes in 1X Tris Buffered saline with Tween 20 
then incubated with either mouse anti-His antibody (1:1000)(Genescript) or rabbit anti-CLIPB9 
antibody (1:500) for at least 1 hour on a rocking shaker (Model 55, MidSci).  The antibody 
solution was removed and the membrane was washed 3 times in 1X Tris Buffered saline with 
Tween 20, 10 minutes. Anti-rabbit or Anti-mouse IgG HRP conjugated antibody (Promega) was 
applied (1:20,000) for 1 hour and placed on rocking shaker.  Antibodies were visualized by 
Western Lightning Chemiluminescence Reagent Plus Kit (Perkin Elmer). 
36 
 
2.3.5 Amidase Activity assays (Commercial) 
Purified rSRPN7 and 18 were tested for inhibitory activity against the following commercially 
available serine proteases: bacterial Subtilisin Carlsberg, fungal protease K, porcine elastase-1, 
human plasmin, bovine trypsin, porcine kallikrein, human thrombin, and bovine chymotrypsin. 
Activity of each protease was tested with different p-nitroanalide (pNa) linked colorimetric 
substrates (See Table 2.1).  Bovine serum albumin (BSA) (Thermo Scientific) was added (3-4 µl 
of 1µg/µl) in each assay to protect the protease from self-cleavage.  SRPN inhibitory activity was 
assessed in triplicate at a 1:1 and 10:1 (SRPN:Protease) ratio by incubating BSA, SRPN and 
protease at room temperature for 10 min followed by addition of 200µl of 50 µM pNA linked 
substrate to reaction and plate was immediately placed in plate reader (BioTek PowerWave Xs). 
Absorbance was measured every 30s, 41 times.  Activity was determined by calculating average 
slope of reads.  One unit of amidase activity was defined as ΔA405/min=0.001. Statistical analysis 
was done using Graphpad Prism 4.  Tests included a one way ANOVA followed by Newman-
Kuels post test.    
Percent inhibition was determined by the equation 2.1: 
1- (Average activity with Serpin/Average Initial activity of Protease only) X 100 
 
Amount of SRPN was calculated by the equation 2.2: 
ng SRPN = Molar Ratio x (ng protease ∕ MW protease) x MW SRPN 
2.3.6 Blood Feeding 
Single cages of 2-3 day old An. gambiae G3 strain mosquitoes were split into two treatment 
groups and placed in separate population cages. Ten females were removed from each cage and 
frozen in liquid nitrogen (Non-Blood fed sample).  One population cage was offered a 
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heparinized horse blood meal for 30 min then another 10 females were removed from each cage 
(0H sample) and frozen in liquid nitrogen.  100 females from each population cage were 
collected (only blood fed for experimental cage) and separated into new population cages.  
Samples were then collected from each at 1, 6, 12, and 24 hours after the 0H time point.   
2.3.7 qRT-PCR 
iQ SYBR GREEN Supermix (Bio-Rad) kit was used as per manufacturer’s specifications.  1µl 
cDNA template was used in each reaction.  Primers were designed using the Primer Express 
Version 3.0.1 and are listed on Table 2.2.  Relative gene expression was determined using the 
ΔΔct method and StepOnePlus RT-PCR machine. RPS7 was used as housekeeping gene.  
Statistical analysis was performed in Graphpad Prism 4. A two-way ANOVA followed by two-
tailed t test was used to compare treatments and time. 
2.3.9 Activation of CLIPB8, B9 
CLIPs were activated using 1µg Factor Xa (New England BioLabs) per 1.5 µg B8 or B9  in 
0.1M Tris + 2mM CaCl2 (final concentration of CLIP 50ng/µl).  1.2µl .05% Tween 20 (Fisher) 
was added per 1µg Factor Xa in CLIPB8 reactions to increase the fraction of activated protease.  
Reactions were incubated at 37º C for 12-36 hours. 
2.3.10 Florescence assays. (B8/B9) 
SRPN7 and 18 protein was tested against recombinant CLIP Serine proteases at 10:1 
SRPN:protease ratio.  rSRPNs were incubated with BSA and protease for ten min at room 
temperature then 100µl of 200µM AMC linked substrate (FVR) was added.  Reactions were 
immediately placed in florescence reader (Wallac Victor
3
 1420 Multilabel counter, PerkinElmer) 
and reads were taken 41 times at 30 second intervals and the slope was calculated.   
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 2.4 Results 
 SRPN7 and 18 RCL implicate SRPN7 as an inhibitory serpin with trypsin-like specify while 
SRPN18 is unlikely to be inhibitory. 
The RCL of known mosquito serpins range from 12 to 47 amino acids, and very few contain less 
than 28.  This is most likely because this number is required for the RCL to stretch over the 
serpin core (Gulley et. al.).  An. gambiae SRPN7 and its orthologs in C. quinquefasciatus and Ae. 
aegypti are canonical serpins with the average RCL length of 28 amino acids and Arg residue at 
the predicted P1 site.  Furthermore, the hinge is conserved and is made up of amino acids 
containing small side chains.  Based on these observations, I hypothesized that An. gambiae 
SRPN7 is an inhibitory serine protease inhibitor with trypsin like specificity.  An. gambiae 
SRPN18, on the other hand has a very short RCL containing only 23 amino acids.  Additionally, 
the hinge region contains an Isoleucine, which has a large side chain as well as a Proline.  The 
presence of proline at even numbers of amino acids away from the sessile bond has been shown 
to decrease inhibitory ability of serpins (Perry et al., 1989; Stein and Carrell, 1995).  The 
decrease may be caused firstly by reducing the flexibility in hinge region and secondly because 
these even numbered amino acids are the ones that get buried into the core of the serpin after 
RCL insertion (Gettins, 2002). Based on this, I predict that SRPN18 is not an inhibitory SRPN 
(Fig. 2.1). 
 Recombinant protein and purification yield pure proteins. 
To investigate the validity of inhibitory activity of these SRPNs, 6-His tagged proteins were 
expressed in an Escherichia coli expression system.  Soluble protein was purified using Nickel 
and Q-sepharose chromatography.  The calculated MW of mature SRPN7 and 18 is 42.9 and 
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42.6 kDa, respectively.  Under reducing conditions SRPN7 and 18 migrated to approximately, 
40kDa on a 10% SDS gel and did not contain any significant contaminating protein shown in 
Figure 2-2 and 2-3. Protein concentration was determined by the Bradford assay using Bovine 
serum albumin (Sigma) as the standard and verified via Nano Drop2000 (Thremo Scientific).  
SRPN7 fraction 13 was used in experiments and its concentration was determined to be 
185ng/µl.  SRPN18 fractions 14-17 were pooled and the final concentration was determined to 
be 1.7 µg/µl. 
 SRPN18 transcripts do not increase after blood meal 
Female anophelines are obligatory hematophagous insects that require protein from the blood 
meal for egg production and expression of 33% of all An. gambiae genes are altered after the 
injection of a blood meal (Marinotti et al., 2005). To determine if SRPN18 expression levels 
change in response to the blood meal, SRPN18 was monitored at different times after blood meal 
and compared to sugarfed mosquitoes.  SRPN18 transcripts did not significantly increase or 
decrease at any timepoint after blood meal (Fig 2.4). 
SRPN7 inhibits Trypsin like serine proteases 
To test for activity of SRPN7 and 18, each serpin was incubated with an array of commercially 
available serine proteases with trypsin (plasmin, trypsin, kallikrein and thrombin), chymotrypsin 
(protease K and chymotrypsin) or elastase (elastase and subtilisin Carlsberg) like activities.  The 
predicted P1 for SRPN7 is Arg which is the preferred amino acid after which trypsin-like serine 
proteases cleave.  SRPN7 inhibited three of the trypsin like serine proteases tested: trypsin, 
plasmin and kallikrein.  SRPN7 inhibited trypsin and plasmin at a 10:1 SRPN:protease ratio and  
kallikrein at a 1:1 and 10:1 ratio.  SRPN18, which has a predicted P1 of Phe, was able to 
marginally inhibit trypsin-like serine proteases, kallikrein, trypsin and plasmin at a 10:1 ratio 
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26.3%, 32.1%, and 20.1% respectively (Fig 2.5).  Assays for SRPN7 and 18 are summarized in 
Table 2.1.  See Appendix for detailed graphs for all assays  
SRPN7 and 18 do not inhibit CLIPB8 or CLIPB9  
In An. gambiae, only CLIPB9 has been shown to be a phenoloxidase activating protease (PAP) 
(An et al., 2011).  Additionally, another CLIP, CLIPB8 has been shown to be involved in the 
PPO pathway, though its biochemical function within the pathway is still unclear (Paskewitz et 
al., 2006).  In an attempt to identify native targets, both SRPNs were incubated with recombinant 
CLIPB8 and CLIPB9.  FVRase activity was measured and compared to the FVRase activity of 
CLIPB8 and B9 alone.  Neither SRPN7 nor 18 were able to decrease the FVRase activity in vitro 
(Fig2.6).  SRPN18 was further analyzed by western blot to confirm that no higher molecular 
weight band appeared (Fig 2.7). 
 2.5 Discussion  
Currently, 18 SRPN genes encoding 23 proteins have been identified in An. gambiae 
(Christophides et al., 2002; Waterhouse et al., 2007; Suwanchaichinda and Kanost, 2009).  Of 
these few have been characterized.  SRPN6 and 10 are both upregulated in response to parasite 
infection and have been proposed as midgut invasion markers (Abraham et al., 2005; Danielli et 
al., 2005).  Additionally, SRPN2 has been shown to be a negative regulator of the melanization 
response and can directly inhibit An. gambiae PAP, CLIPB9 (An et al., 2011).  SRPN1 has been 
implicated in the PPO pathway as it can inhibit M sexta PAP3, and prevent spontaneous 
melanization of M sexta plasma in vitro (Michel et al., 2006).  The function of all other SRPNs 
remains to be shown.  In this study two additional SRPNs, SRPN7 and 18 were biochemically 
characterized.  
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SRPN7 is a mosquito specific SRPN, and previous expression profiles have shown that it is most 
highly expressed in larvae but it is expressed at low levels in adults, mainly in female heads 
(Michel et al., 2005; Suwanchaichinda and Kanost, 2009; Baker et al., 2011).  It maintains a 
canonical RCL with conserved residues in key areas necessary for the dramatic conformational 
change associated with serpin inhibition.  SRPN7 was predicted to be an inhibitory serpin of 
serine proteases with trypsin-like specificity.  This was verified by the inhibitory effects on the 
trypsin like serine proteases tested (trypsin, plasmin and kallikrein) as well as its lack of 
inhibition of chymotrypsin and elastase like serine proteases.   
One to one orthologs of all An. gambiae serpins can be found in Ae. aegypti and C. 
quinquefasciatus with the notable exception of SRPN13 and 18.  SRPN18 has only recently been 
annotated (Waterhouse et al., 2007), and is expressed in most tissues (Marinotti et al., 2005) and 
throughout all life stages (Suwanchaichinda and Kanost, 2009).  SRPN18 clusters with SRPN7 
and 14 close to the SRPN2 cluster on chromosome arm 2L.  Based on the conservation of key 
amino acids making up the RCL and identity of the predicted P1, SRPN18 was predicted to be a 
non-inhibitory SRPN.  When SRPN18 was tested against an array of commercially available 
serine proteases marginal inhibition of trypsin like serine proteases (trypsin, plasmin, and 
kallikrein) at high SRPN:protease ratios was observed.  This could be explained by erroneous P1 
prediction for SRPN18 of Phe.  Alternately, SRPN18 may have acted as a substrate for these 
proteases.  The protease could cleave SRPN18 at alternate sites besides the P1.  Alternately, if 
the protease cleaves at the P1 quickly enough the serpin will not have sufficient time to insert 
into the β sheet and will instead function as a substrate.  This would seem to be more likely as we 
only see marginal decrease in protease activity at the higher SRPN:protease ratio and can be 
tested by N-terminal sequencing.  SRPN18 did not inhibit chymotrypsin-like serine proteases 
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which further substantiates the prediction that SRPN18 in not functioning as a typical serine 
protease inhibitor.  Further analysis showed that SRPN7 and 18 were unable to inhibit two 
CLIPs, CLIPB8 and CLIPB9, known to be involved in the melanization response in An. 
gambiae.   
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 2.7 Tables  
 
Table 2.1:  SRPN7 and 18 inhibition of commercially available proteases 
 
 
46 
 
Table 2.2:  Primer sequences 
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2.8 Figure Legends 
Figure 2-1:  Amino acid sequence alignment of reactive center loops from AgSRPNs and 
homologues 
Alignment of An. gambiae SRPN7 and 18 reactive center loop with orthologous genes in Aedes 
aegypti and Culex quinquefasciatus.  Alignment was performed in “Clustal Omega"(Sievers et 
al., 2011).  Predicted scissile bond is indicated by red line.  Consensus sequence is on bottom.  
Hinge region is in blue. 
 
Figure 2-2:  SRPN 7 Recombinant Protein Expression and Purification 
Coomassie Blue 
TM 
stained 10% SDS gel after (A) Nickel (Ni-NTA) affinity chromatography or 
(B) Q-Sepharose chromatography.  (A) From left to right:, Pre-induction (PI), Hours post protein 
induction (hpi) 1, 4, 7, Insoluble protein (IS), Soluble protein(S), Marker (M), Flow Thru (FT), 
Wash 1, 2,  Elutions 1-4, Marker (M).  Protein was eluted out in 300mM NaCl + 250mM 
imidazole pH= 8.0. (B) Protein was run through column containing Q-Sepharose beads washed, 
and eluted in a 50-500mM pH= 8.0 linear NaCl gradient. From right to left Flow Thru (FT), 
Wash (W), and elutions 2-27. 
 
Figure 2-3:  SRPN18 Recombinant Protein Expression and Purification 
Coomassie Blue 
TM 
stained 10% SDS gel after (A) Nickel (Ni-NTA) affinity chromatography or 
(B) Q-Sepharose chromatography.  (A) From left to right: Marker (M), Pre-induction (PI), Hours 
post protein induction (hpi) 1, 6, 18, Insoluble protein (IS), Soluble protein(S), Flow Thru (FT) 
1, 2, Wash 1, 2,  Elutions 1-4.  Protein was eluted out in 300mM NaCl + 250mM imidazole pH= 
8.0. (B) Protein was run through column containing Q-Sepharose beads washed, and eluted in a 
50-500mM pH= 8.0 linear NaCl gradient. From right to left Marker (M), and elutions 2-29. 
 
Figure 2-4:  SRPN18 transcripts do not change after blood meal 
qRT-PCR analysis of SRPN18 transcript abundance . Relative expression of SRPN18 after blood 
meal time course.  Expression was normalized to RPS7. Nonblood fed control samples were used 
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as calibrator.  Statistical tests performed is 2 way ANOVA. Error bars are mean and SEM of 
three replicates 
 
Figure 2-5:  SRPN7 and 18 inhibition of commercial proteases  
(A) SRPN7 protein was incubated with plasmin or (B) SRPN18 incubated with kallikrein for ten 
minutes at room temperature at different SRPN:protease molar ratios.  200 µl of 50µM substrate 
(PFR-pNA or IEGR-pNA respectively) was added and absorbance was measured immediately 
every 30 s for 41 times at 405nm. Bar graphs represent residual activity and dot graphs represent 
individual reads during the assay. Error bars are mean and SEM of three biological replicates. 
 
Figure 2-6:  SRPN7 and 18 do not inhibit CLIPB8 or B9 
SRPN7 or 18 was incubated with Factor Xa activated (A) CLIPB9 or (B) CLIPB8 at room 
temperature for Ten minutes.  FVR-AMC was used as substrate and FVRase activity was 
measured immediately every 30 s for 41 times.  Error bars are mean and SEM of three biological 
replicates. 
 
Figure 2-7:  SRPN18 does not form complex with CLIPB8 or B9 
Activation of recombinant CLIPB8 and CLIPB9 and no complex formation via Western Blot 
analysis using anti-His antibodies 
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2.9 Figures 
Figure 2-1:  Amino acid sequence alignment of reactive center loops from AgSRPNs and 
homologues 
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Figure 2-2:  SRPN 7 Recombinant Protein Expression and Purification 
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Figure 2-3:  SRPN 18 Recombinant Protein Expression and Purification 
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Figure 2-4: Blood meal has no effect on SRPN18 transcript abundance. 
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Figure 2-5:  SRPN inhibition of commercial proteases  
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Figure 2-6:  SRPN7 and 18 do not inhibit CLIPB8 or B9 
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Figure 2-7: SRPN18 does not form complex with CLIPB8 or B9 
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Chapter 3 - Biochemical Characterization of SRPN9 
 3.1 Abstract 
One important aspect of Anopheline immunity is melanization, the encapsulation of pathogens in 
the insoluble pigment eumelanin.  This immune response is partly responsible for certain strains 
of mosquitoes being refractive to Plasmodium sp, infection.  Melanization occurs after pathogen 
recognition stimulates extracellular CLIP domain serine protease (CLIPs) cascades. Clips 
circulate as zymogens and are sequentially activated.  In the melanization pathway, terminal 
CLIPs known as prophenoloxidase activating proteases (PAPs), ultimately cleave inactive 
prophenoloxidase (PPO) to Phenoloxidase (PO).  PO converts mono and diphenols to quinones 
which polymerize to eumelanin.  This process is thought to limit oxygen accessibility, essentially 
suffocating the pathogen.  Due to harmful byproducts of eumelanin synthesis, such as 
superoxides, semi-quinones and reactive oxygen species, these cascades are tightly regulated by 
one class of serine protease inhibitors, called serpins (SRPNs).  Although reverse genetic 
approaches have identified several CLIPs that act as agonists/antagonists in the melanization 
response, the extracellular protease cascade is largely unknown.  To date in An. gambiae, only 
SRPN2 has been shown to be a negative regulator of a terminal phenoloxidase activating 
protease (PAP), CLIPB9.  Using biochemical techniques I characterized SRPN9 as a suicide 
inhibitor.  I found that SRPN9 was not able to inhibit CLIPB8 but did inhibit known PAP, 
CLIPB9.  Kinetic analysis of SRPN9 and CLIPB9 showed that that Stoichiometry of Inhibition 
is 1.33 and the rate of association (ka) for this SRPN to protease is 9.8x10
4
M
-1
s
-1
.  Overall these 
data show An. gambiae SRPN9 is a functional serine protease inhibitor of trypsin-like serine 
proteases and of CLIPB9 in particular. 
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 3.2 Introduction 
Serpins are the largest family of serine protease inhibitors found ubiquitously in prokaryotes as 
well as eukaryotes. These inhibitors tend to inhibit serine proteases with trypsin like specificity 
while others have evolved to perform different biological functions such as storage proteins and 
molecular chaperones (Hunt and Dayhoff, 1980; Flink et al., 1986).  These metastable proteins 
contain 350-400 amino acids, are chiefly secreted and circulate in a stressed (S) state (Carrell and 
Owen, 1985).  They share limited sequence similarity, yet are structurally conserved.  The body 
of the serpin contains up to nine β-sheets surrounded by α-helices. A so-called reactive center 
loop (RCL) sits out from the body of the protein and acts as a lure for target proteases.  The 
catalytic serine of the target protease performs nucleophilic attack on the sessile bond (denoted 
P1-P1’) of the serpin. Upon cleavage of the RCL, the SRPN undergoes a massive conformational 
change in which the RCL flips around and inserts into β-sheet A (Huntington et al., 2000).  As 
this insertion occurs an acyl intermediate (Lawrence et al., 1995) is formed followed by covalent 
bond formation between the serpin and protease.  This traps the protease and destroys its active 
site as the protease is dragged to the opposite pole of the serpin (Huntington et al., 2000).  
Serpins are known as suicide inhibitors because both the protease and the SRPN are irreversibly 
inhibited in this interaction (Gettins, 2002). 
Extracellular immune cascades in insects, such as the PO activation pathway, consist of 
sequentially activating serine proteases.  These serine proteases contain an N-terminal disulfide 
knotted domain (called a paperclip like domain) and a C-terminal trypsin-like protease domain 
held together by a linker region (Muta et al., 1990).  CLIPs are a large family of proteins.  Fifty-
six CLIPs have been identified in An. gambiae (Waterhouse et al., 2007) yet few show 1:1 
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orthology indicating species specific gene expansion(Christophides et al., 2002).  Many CLIPs 
are continually expressed at a basal level which allows them to be quickly activated in an acute 
phase response to pathogens. CLIPs circulate in arthropod hemolymph in an inactive zymogen 
form and are activated by cleavage between the CLIP domain and the catalytic domain by 
limited proteolysis (Muta et al., 1990).  Additionally, several CLIPs (CLIPAs and Es) are non-
catalytic proteases called serine protease homologues (SPH) and instead function as co factors 
needed for the propagation of the PO signal (Nappi et al., 2009).  Ten CLIPAs have been 
identified in the An. gambiae genome (Christophides et al., 2002).  Three, CLIPA2, A5, and A7 
are putative SPH and are involved in melanization of parasites (Volz et al., 2006). 
Previous studies using reverse genetics and biochemical techniques have shown several CLIPBs 
(CLIPB3, B4, B8, B9, B14, B17) to be involved in the melanization response(Volz et al., 2005; 
Paskewitz et al., 2006; Volz et al., 2006; An et al., 2011).  Of the 18 genes encoding 23 distinct 
SRPNs in An. gambiae only SRPN2 has been shown to inhibit a phenoloxidase activating 
protease (PAP), CLIPB9(An et al., 2012).  An. gambiae SRPN9 orthologs, D. melanogaster 
Spn5 and M. sexta Serpin-6, negatively regulate Toll and PPO activity (Zou and Jiang, 2005; 
Ahmad et al., 2009).  Here, we test whether SRPN9 is a functional serine protease inhibitor that 
can prevent hemolymph melanization in insects. 
 
 3.3 Materials and methods 
3.3.1Mosquito Rearing 
An. gambiae G3 line was used in these experiments.  Females were allowed to oviposit on wet 
filter paper then floated in water to allow hatching.  For 48 hours larvae were fed on 2% baker’s 
yeast (Red Star, Active Dry Yeast) then switched to 2% w/v fish food (TetraMin Tropical 
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Flakes, Tetra) and baker’s yeast 2:1 ratio.  Adult mosquitoes were fed on an 8% fructose + 
2.5mM PABA (Sigma) solution ad libitum, and heparinized horse blood (Plasvacc) was fed 
through an artificial glass feeder using parafilm as a membrane.  All stages were reared at 80% 
humidity, 27ºC and a 12:12 light:dark cycle. 
3.3.2 Mosquito Injection 
Female mosquitoes were collected 2-3 days post emergence, placed in paper cups and provided 
sugar water.  Females were anesthetized by exposure to CO2 and injected (Drummond 
Nanoject
TM 
II) with 69nl of dsRNA (2.89µg/µl).  Mosquitoes were allowed to recover in paper 
cups and sugar water was supplied.  Survival was recorded daily. 
3.3.3 SRPN9 Cloning  
A cDNA fragment encoding the full-length mature SRPN9 was amplified using the gene-specific 
primers listed in Table 3-4. The forward primer included an NcoI site and the reverse primer 
contained an ECOR1 restriction site.  A second round of PCR was performed and the forward 
primer contained six codons for histidine residues.  The reverse primer is the same as round 1 
PCR.   The PCR product was digested with NcoI and EcoR1, and then inserted into the same 
restriction sites into a pET-28a vector (Novagen).  The plasmid was transformed into BL21 
(DE3) competent E. coli cells and stored at -80º.  Cloning was done previously by Mrs. Tinea 
Canady. 
3.3.4 Recombinant Proteins  
To biochemically characterize SRPN9, recombinant SRPN9 protein was expressed using an 
Escherichia coli expression system.  The full coding region, minus the predicted signal peptide, 
was amplified using gene specific primers. SRPN9 protein was expressed using BL-21 DE3 
competent E. coli cells.  Cells containing plasmid were grown overnight at 37˚C from bacterial 
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stocks on LB agar plates containing 50µg/ml kanamycin.  A single colony was inoculated into 
250 ml flask containing 50ml LB containing and 50µg/ml Kanamycin then shook overnight at 
37˚C 150rpm.  15ml of the overnight culture was used to inoculate 2, 2 liter flasks of 500ml LB 
with 50µg/ml Kanamycin.  Inoculated culture was incubated at 37.0˚C and shook at 225rpm for 
approximately 2 hours to an OD600 between 0.6-0.8.  Protein expression was induced using 
0.1mM IPTG and incubated at least 8 hours at 20 ˚C, 150rpm.  The culture underwent 
centrifugation 4000rpm 20 minutes and the pellet was kept at -80˚C.   
3.3.5 Recombinant Protein Purification  
Pellet from expression was re-suspended in lysis buffer (300mM NaCl + 10mM imidazole) 4 ml 
buffer/grams pellot.  Cells were lysed by sonication (Vibra Cell High Intensity Ultrasonic 
Processor 750 Watt model) and soluble and insoluble fractions were separated by centrifugation 
at 10,000g for 40min at 4.0˚C.  Soluble portions were retained and purified by running the 
sample through a column containing 2 ml Ni-NTA (Qiagen) beads.  Bound proteins were washed 
twice with wash buffer (20ml 300µM NaCl + 20mM imidazole) to remove unbound proteins.  
Bound proteins were eluted in 4, 5ml fractions using elution buffer (300µM NaCl + 250mM 
imidazole).  Salts were removed by dialysis, three times for eight hours in dialysis buffer (20mM 
Tris + 20mM NaCl, pH = 8.)  The sample was further purified by running the sample through 
column containing 2 ml Q Sepharose Fast Flow beads (GE Healthcare) equilibrated with 20mM 
Tris + 20mM NaCl.  Unbound proteins were removed by 10 ml wash buffer (20mM Tris + 
20mM NaCl).  Protein was eluted off the column by a low to high salt gradient (50-200mM 
NaCl+20mM Tris). Fractions were analyzed by 10% SDS-PAGE and pooled.  Protein 
concentrations were determined by Bradford assay using Comassie Plus Protein Assay Reagent 
(Pierce) and bovine serum albumin as a standard (Sigma). 
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3.3.6 SRPN9 Polyclonal Antibody Production 
500µg recombinant SRPN9 protein was ran on 10% SDS-PAGE gel and stained with EZ-Run 
Protein Gel Staingin solution (Fisher).  The gel containing SRPN9 was cut in slices and sent by 
Mrs. Tinea Cannady to produce polyclonal rabbit antisera (Cocalico).  Antibodies were purified 
by incubating antibodies with 400µg SRPN9 bound to a nitrocellulose membrane (GE 
Healthcare) overnight at 4˚C.  Antibodies that did not bind to SRPN9 were washed from the 
nitrocellulose membrane 3 times with 1% Tris-Tween Buffered Saline (TTBS) to cover 
membrane. Purified SRPN9 antibodies were eluted in 3, 1 ml elutions of  0.2M glycine and 1M 
tris base, pH= 7.5 elutions and stored at -80ºC in 30 ml aliquots.  
3.3.7 SDS-PAGE electrophoresis and Western Blotting 
Recombinant proteins were denatured with 6X SDS buffer containing β-mercaptoethanol for 5 
minutes at 95 ºC.  The samples were then separated using 10% SDS-PAGE electrophoresis for 
20 min at 100 volts followed by 40 min at 180 volts.  The gel was stained with EZ-Run Protein 
Gel Staining solution (Fisher).  For immunoblot analysis proteins were transferred to PVDF 
membrane (GE Healthcare) at 0.110 Amps for 1 hour.  Membranes were blocked in 5% skim 
milk for 1 hour and washed 3 times for 10 minutes in 1X Tris Buffered saline with Tween 20 
then incubated with either rabbit anti-SRPN9 antibody (1:500) or rabbit anti-CLIPB9 antibody 
(1:500) for at least 1 hour on a rocking shaker (Model 55, MidSci).  The antibodies were 
removed and the membrane was washed 3 times in 1X Tris Buffered saline with Tween 20, 10 
minutes. Anti-rabbit IgG HRP conjugated antibody (Promega) was applied (1:20,000) for 1 hour 
and placed on rocking shaker.  Antibodies were visualized by Western Lightning 
Chemiluminescence Reagent Plus Kit (Perkin Elmer). 
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3.3.8 Amidase Activity assays (Commercial) 
Purified rSRPN9 was tested for inhibitory activity against the following commercially available 
serine proteases: bacterial Subtilisin Carlsberg, fungal protease K, porcine elastase-1, human 
plasmin, bovine trypsin, porcine kallikrein, human thrombin, and bovine chymotrypsin. Activity 
of each protease was tested with a p-nitroanalide (pNa) linked colorimetric substrates (See Table 
3.1).  Bovine serum albumin (BSA) (Thermo Scientific) was added (3-4 µl of 1µg/µl) in each 
assay to protect the protease from self-cleavage.  SRPN inhibitory activity was assessed in 
triplicate at a 1:1 and 10:1 (SRPN:Protease) ratio by incubating BSA, SRPN and protease (See 
Table3-2) at room temperature for 10 min followed by addition of 200µl of 50 µM pNA linked 
substrate to reaction and plate was immediately placed in plate reader (BioTek PowerWave Xs). 
Absorbance was measured every 30s, 41 times.  Activity was determined by calculating average 
slope of reads.  One unit of amidase activity was defined as ΔA405/min=0.001. Statistical analysis 
was done using Graphpad Prism 4.  Tests included a one way ANOVA followed by Newman-
Kuels post test.    
Percent inhibition was determined by the equation 3.1: 
1- (Average activity with Serpin/Average Initial activity of Protease only) X 100 
 
Amount of SRPN was calculated by the equation 3.2: 
ng SRPN = Molar Ratio x (ng protease ∕ MW protease) x MW SRPN 
3.3.9 Blood Feeding 
Single cages of 2-3 day old mosquitoes were split into two treatment groups and placed in 
separate population cages. Ten females were removed from each cage and frozen in liquid 
nitrogen (Non-Blood fed sample).  One population cage was offered a heparinized horse blood 
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meal for 30 min then another 10 females were removed from each cage (0H sample) and frozen 
in liquid nitrogen.  100 females from each population cage were collected (only blood fed for 
experimental cage) and separated into new population cages.  Samples were then collected from 
each at 1, 3, 12, and 48 hours after the 0H time point.   
3.3.10 RNA Isolation 
Frozen mosquitoes were homogenized in 1ml Trizol and centrifuged at 15000 rpm, 4˚C for 30 
min.  Aqueous phase was collected and RNA was precipitated using isopropanol.  RNA was 
pelleted by centrifugation at 15000 rpm, 4˚C for 30 min and washed twice in 70% ethanol.  RNA 
was dissolved in 100 µl RNase free water and stored at -80˚C.  DNA was removed by DNase 
digestion.  Isolated RNA was mixed with 11.5µl Buffer RDD (Qiagen) and 2.88 µl DNase1 
(Qiagen) (2.7unit/µl) and incubated at RT for 10 minutes.  RNA CLEAN-UP was performed as 
per manufacturer’s instructions (Quiagen RNeasy Mini-kit). RNA quality was assessed by 
Agilent BioAnalyzer using a nano chip as per manufacturer’s instructions and concentration was 
determined by Nanodrop 8000.   
3.3.11 cDNA Synthesis 
cDNA Synthesis was performed in 20µl reaction volumes. 2 µl of 50ng/µl total RNA was used 
with the iSCRIPT cDNA Synthesis kit, as per manufacturer’s instructions.   
3.3.12 qRT-PCR 
iQ SYBR GREEN Supermix (Bio-Rad) kit was used as per manufacturer’s specifications.  1µl 
cDNA template was used in each reaction.  Primers were designed using the Primer Express 
Version 3.0.1 and are listed on Table 3.4.  Relative gene expression was determined using the 
ΔΔct method and StepOnePlus RT-PCR machine. RPS7 was used as housekeeping gene.  
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Statistical analysis was performed in Graphpad Prism 4. A two-way ANOVA followed by two-
tailed t test was used to compare treatments and time. 
3.3.13 dsRNA synthesis 
Gene specific primers with T7 tails were designed using E-RNAi webservice (version 3.2)(Horn 
and Boutros, 2010), see Table 3-4. Vector plasmid Pet28a (Novagen) containing the SRPN9 gene 
was amplified the gene using Promega Go taq kit.  All PCR product was gel extracted using 
Quiagen Gel Extraction Kit and used as template for 2
nd
 PCR using T7 primers.  DNA was 
precipitated in isopropanol at -20˚C for at least one hour, and then pelleted by 30 minutes 
centrifugation at 13000rpm at 4 ˚C.  DNA was washed twice with one ml 70% ethanol.  1µg of 
purified PCR product was used as template for dsRNA synthesis in a 20µl reaction volume as 
per Ampliscribe T7-Flash Transcription kit (Epicenter) instructions.  Reaction mixture was 
treated with RNase Free DNase1 (2.7 units/µl) for 20min at 37 ˚C to remove DNA template and 
RNase free water was added to total volume of 300 µl.  RNA was extracted with equal volumes 
of Phenol/Chloroforn/Isoamyl alcohol (Fisher) and separated from chloroform by centrifugation.  
The aqueous phase was transferred into a new tube and RNA was precipitated with isopropanol 
for 1 hour at -20ºC.  RNA was pelleted by centrifugation 30 minutes at 4ºC.  The supernatant 
was removed and RNA was washed twice with one ml 70% ethanol.  Pellet was dissolved in 30 
µl dd RNase free water and diluted to 2.89 µg/µl.   
3.3.14 PO activity assays 
Plasma was collected by gravity from 2 day 5
th
 instar Manduca sexta larvae by clipping the horn 
with dissecting scissors.  Hemocytes were removed by centrifugation in a tabletop Eppendorf 
centrifuge at 8000 rpm for 10 minutes and stored at -80ºC.  Plasma collection was done by Dr. 
Kristin Michel.  The plasma was incubated for 10 min with 0, 100, 200 or 400ng SRPN9 at room 
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temperature.  Subsequently, proPO activity was activated in the reaction mixture by adding 10µg 
Micrococcus luteus (Sigma) and incubating the reaction at room temperature for 10 minutes.  
200µl of 2mM dopamine-HCL was added to the reaction and immediately placed in plate reader 
(BioTek PowerWave Xs) Absorbance was measured 60 times at 30 second intervals.  Statistical 
tests were performed in Graphpad Prism 4.  Tests included a one way ANOVA followed by 
Newman-Kuels post test.   
3.3.15 Activation of CLIPB8, B9 
CLIPs were activated using 1µg Factor Xa (New England BioLabs) per 1.5 µg B8 or B9  in 
0.1M Tris + 2mM CaCl2 (final concentration of CLIP 50ng/µl).  1.2µl .05% Tween 20 (Fisher) 
was added per 1µg Factor Xa in CLIPB8 reactions to increase the fraction of activated protease.  
Reactions were incubated at 37º C for 12-36 hours. 
3.3.16 Florescence assays. (B8/B9) 
SRPN9 protein was tested against recombinant CLIP Serine proteases at a 10:1 SRPN:protease 
ratio.  SRPN9 was incubated with BSA and protease for ten min at room temperature then 100µl 
of 200µM AMC linked substrate (FVR) was added.  Reactions were immediately place in 
florescence reader (Wallac Victor
3
 1420 Multilabel counter, PerkinElmer) and reads were taken 
every 41 times at 30 second intervals and the slope was calculated.   
 3.3.17 Stoichiometry of Inhibition  
Different molar ratios of SRPN9 (6:1, 4:1, 2:1, 1.5:1, 1:1, .5:1, 0:1) was incubated with 100ng 
CLIPB9 and 3µgBSA at room temperature for ten min.  100µl of 300µM FVR-AMC substrate 
was added and FVRase activity was measured every 30 sec, 61 times.  Percent residual activity 
was calculated and plotted against SRPN9:CLIPB9 molar ratio.  X intercept, when Y=0 of linear 
regression of this data gives SI. 
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3.3.18 Association Constant  
100µl of 300µM FVR-AMC was added to SRPN9 at 0, 4.3, 8.6, 13, 17.3, 25.9, 34.5 and 51.8 nM 
plus 213nM BSA.  Activated CLIPB9 (2.37pmol) was added and FVRase activity was measured 
50 times every thirty seconds.  kobs is calculated by nonlinear regression for each serpin:protease 
concentration (see equation below).  kobs is plotted against respective serpin:protease 
concentration.   Linear regression of this gives a line.  k' was calculated as the slope of this line. 
ka was calculated (See below)   
P=V0/ kobs[1-e
(1- kobst)
]  P=concentration of product at time (t) 
ka = k' (1+ [FVR]/KM(FVR))SI        
 
 3.4 Results 
 3.4.1 SRPN9 has a canonical reactive center loop and is predicted to be inhibitory 
Previous studies showed that SRPN9 orthologues in D. melanogaster and M. sexta are important 
regulators of TOLL and PO pathways (Zou and Jiang, 2005; Ahmad et al., 2009).  To predict if 
An. gambiae SRPN9 could be inhibitory and whether it may play similar roles as its orthologs, 
the RCL was aligned with D. melanogaster, M. sexta, A. aegypti, C. quinquefasciatus, A. 
mellifera orthologs and canonical serpin, human α-1-antitrypsin.  (Fig 3-1) Many inhibitory 
serpins are cleaved by proteases with trypsin-like specificity, which tend to cleave after Arg or 
Lys. Arg at the predicted P' of the RCL for all SRPN9 orthologus thus suggests that these serpins 
will inhibit trypsin-like serine proteases.  Additionally, overall sequence similarity of the SRPN9 
RCL with that of its orthologes, suggests that AgSRPN9 is likely inhibitory and has similar 
targets and functions in An gambiae. 
3.4.2 Recombinant SRPN9 expression and purification yielded pure protein 
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To investigate biochemical properties such as SRPN9 inhibitory activity and potential targets, 6-
His tagged SRPN9 was expressed in an E. coli expression system.  Soluble protein was purified 
using Nickel and Q-sepharose chromatography.  The calculated molecular weight of rSRPN9 is 
48.0 kDa and under reducing condition rSRPN9 migrated to 50 kDa on a 10% SDS gel and did 
not contain any significant contaminating protein. (Figure 3-3) Fractions 13-17 were pooled and 
yielded 5mg of rSRPN9 in a total volume of 5 ml. rSRPN9 concentration was determined to be 
1.1µg/µl by Bradford assay using Bovine serum albumin (Sigma) as the standard and verified via 
Nano Drop2000 (Thremo Scientific).  Nucleic acid and deduced amino acid sequences are shown 
in Figure 3-2. 
 3.4.3 SRPN9 depletion does not affect mosquito survival 
Knockdown of SRPN9 by dsRNA did not affect survival when compared to GFP injected 
controls.  Unlike SRPN2, another CLIPB9 inhibitor, there was no visible phenotype associated 
with SRPN9 depletion, yet SRPN9 is indeed depleted in dsRNA injected females. (Fig. 3-4)   
 3.4.4 SRPN9 increases after blood meal 
Female anophelines are obligatory hematophagous insects that require protein from the blood 
meal for egg production.  The ingestion of blood causes altered expression of 33% of all An. 
gambiae genes (Marinotti et al., 2005). To determine if SRPN9 expression levels change in 
response to the blood meal, SRPN9 was monitored at different times after blood meal and 
compared to sugarfed mosquitoes.  Similar to experiments in A. aegypti, SRPN9 levels increase 
over time after ingestion of a blood meal. (Fig. 3-5) 
 3.4.5 SRPN9 inhibits trypsin-like serine proteases 
Based on the sequence analysis I predicted that rSRPN9 would inhibit trypsin-like serine 
proteases based on the Arg at the predicted P1.  To test this hypothesis and determine the 
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inhibitory activity and specificity, rSRPN9 was tested against an array of commercially available 
proteases.  Percent inhibition was calculated as described in Materials and Methods and is 
summarized in Table 3-2.  As predicted, SRPN9 was able to inhibit all tested trypsin like 
proteases: plasmin, trypsin, kallikrein, and thrombin at a 10:1 SRPN:protease ratio, and all but 
thrombin at a 1:1 ratio.  Interestingly, SRPN9 was also able to inhibit chymotrypsin at both a 
10:1 as well as a 1:1 ratio. (Fig 3-6)  Individual replicates for each SRPN:Protease are shown in 
Appendix A. 
 3.4.6 rSRPN9 decreases M. sexta phenoloxidase activity 
Biochemical analysis on mosquito hemolymph is difficult due to the limited volume per adult 
that can be collected.  To determine if SRPN9 may be involved in inhibiting PO activity, the well 
characterized M. sexta system was utilized.  Increasing amounts of rSRPN9 were incubated with 
M. sexta hemolymph then PO activity was stimulated by addition of M. luteus.  Addition of 400, 
200 and 100ng rSRPN9 decreased PO activity by 58.8, 49.5 and 29.4% respectively.  rSRPN9 
was able to significantly decrease PO activity in M. sexta plasma in a dose dependent manner 
presumably by inhibiting a protease or proteases in the PO activating cascade. (Fig 3-7) 
3.4.7 rSRPN9 forms SDS stable complex with rCLIPB9 but not rCLIPB8 
CLIPB8 and CLIPB9 are involved in the melanization reaction in An. gambiae (Paskewitz et al., 
2006; An et al., 2011) and CLIPB9 is a PAP able to directly activate phenoloxidase (An et al., 
2011).  To study the potential inhibitory effects of SRPN9 on these proteases, rSRPN9 was 
incubated at room temperature with bovine Factor Xa activated rCLIPB8Xa and rCLIPB9Xa.  
FVRase activity was measured and complex formation was investigated by Western blot analysis 
using anti-CLIPB8, anti-CLIPB9 and anti-SRPN9 antibodies.  Western blot analysis showed 
rSRPN9 was able to form complex with rCLIPB9Xa.  Incubation of rSRPN9 and rCLIPB9Xa 
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showed the appearance of a high molecular weight band approximately 75kDa, which is the 
expected mass of CLIPB9/SRPN9 complex.  This complex was recognized by anti-SRPN9 and 
anti-CLIPB9 antibodies. (Fig 3-8)  To determine if the high molecular weight band was indeed a 
complex of rSRPN9 and rCLIPB9, rSRPN9 and rCLIPB9 were incubated and ran on a 10% 
SDS-PAGE gel.  The gel was stained with EZ-Run Protein Gel Staining solution.  The high 
molecular weight band was excised (Fig 3-9) and analyzed by 1D NanoLC ESI MS/MS.  
MS/MS confirmed that rSRPN9 and rCLIPB9 could form a complex as they were present in the 
high molecular weight band (approximately 75 kDa).  (Table 3-3) 
 3.4.8 rSRPN9 to rCLIPB9 has low SI and similar ka as other arthropod serpin protease 
combinations 
Kinetic analysis was performed to determine the stoichiometry of inhibition (SI) and rate of 
association (ka) of rSRPN9 and rCLIPB9Xa under pseudo-second order rate conditions.  The SI 
was determined by incubating increasing SRPN:protease molar ratios for 10 min at room 
temperature. Percent residual activity was plotted against SRPN:protease molar ratio. SI is 
extrapolated by X when Y=0, or the SRPN:protease ratio at which the protease has zero activity.  
The ka was measured by mixing different molar ratios of SRPN:protease and immediately 
measuring FVRase activity.  Kobs was calculated by nonlinear regression.  The slope of this line 
equals k', which is used to calculate the association rate ka = k' (1 + [S]/KM) SI.  1.3 molecules of 
SRPN9 was able to inhibit 1 molecule of CLIPB9 (Fig. 3-10).  The calculated Ka of SRPN9 for 
CLIPB9 was 9.8x10
4
M
-1
s
-1 
which is within the range of known serpins.  (Fig. 3-11) This data 
shows that in vitro, rSRPN9 is acting as a good inhibitor of this PAP. 
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 3.5 Discussion  
In mammals, extracellular serine proteases are involved in a variety of processes from wound 
healing, blood coagulation, fibrinolysis, and complement activation (Hunt and Dayhoff, 1980; 
Patston et al., 1991).  In arthropods, these serine protease cascades are involved in dorsal-ventral 
axis patterning, Toll activation, melanization, and coagulation.  Serpins are the largest group of 
inhibitors of serine proteases in metazoans, which can inhibit multiple targets as can be seen in 
M. sexta serpin-6, which can form complexes with HP8, PAP-3 and immulectin-2.  This is also 
observed in mammals, for example Plasminogen activator inhibitor-1 can inhibit tissue-type 
plasminogen activator and the urokinase-type plasminogen activator (Zou and Jiang, 2005) 
(Fortenberry, 2013).   
The inhibitory activity of serpins can be predicted based on the composition of the RCL.  Target 
proteases cleave the peptide bond between the P1 and P1'.  Based on the distance from the hinge 
region, the P1 for SRPN9 in An. gambiae is Arg (Gulley et al., 2013) and thus SRPN9 is 
predicted to inhibit proteases with trypsin-like specificities.  This is supported as SRPN9 had no 
effect on subtilisin-like proteases subtilisin Carlsberg and protease K or elastase-like serine 
protease porcine elastase-1 which preferentially cleave after small neutral amino acids.  This is 
further supported as SRPN9 was able to reduce trypsin, plasmin and kallikrein activity by 38.6, 
75.6, and 96.8% respectively at a 1:1 SRPN to protease ratio.  At a 10:1 ratio over 90% of the 
amidase activity of all three proteases was inhibited.  SRPN9 appears to be a promiscuous 
inhibitor as it was also able to significantly inhibit chymotrypsin, which prefers to cleave after 
aromatic amino acids, at a 1:1 and 10:1 ratio (49.9 and 81.9%, respectively).  This suggests that 
Phe at the predicted P2 position can also act as the P1.  The identity of the P1 in these different 
reactions will have to be confirmed experimentally, and if proven would be a novel idea.   
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Melanization is important in limiting successful parasite numbers within the mosquito in 
laboratory vector/parasite pairs (Collins et al., 1986).   The first step in determining if SRPN9 
was a physiologically relevant regulator of melanization in An. gambiae was to directly test its 
ability to reduce PO activity in an ex vivo system.  SRPN9 was able to decrease PO activity in M. 
sexta hemolymph in a dose dependent manner.  To further investigate the mechanism for this 
inhibition, SRPN9 was tested against An. gambiae CLIPs.  Although CLIPB8 has yet to be 
biochemically characterized it has a predicted role in melanization (Paskewitz et al., 2006) and 
CLIPB9 can directly activate PPO to PO (An et al., 2011).  SRPN9 had no inhibitory effect on 
CLIPB8 but was able to significantly decrease amidase activity of the only known An. gambiae 
PAP, CLIPB9.  Furthermore, Western blot and Mass Spec analysis confirm that rSRPN9 and 
rCLIPB9 were able to form an SDS stable covalent complex in vitro. Biochemical 
characterization of rSRPN9 and rCLIPB9 also proves that SRPN9 is a good inhibitor of CLIPB9 
with a low SI (1.3) and a Ka similar to other arthropod serpins (9.8x10
4
M
-1
s
-1
).  
Due to its ability to inhibit many different serine proteases, across classes (trypsin like and 
chymotrypsin like) it is likely that SRPN9 may have different functions in various tissues.  
Similar to its orthlogs it may be involved in Toll regulation.  SRPN9 expression increases after 
blood meal and is expressed in midguts and salivary glands.  Taken with the data that show 
SRPN9 is able to inhibit blood serine proteases (plasmin and thrombin) it may also be involved 
in inhibiting blood proteases.  SRPN9 may be functioning as the female attempts to obtain the 
blood meal or in the midgut after the blood meal is acquired.  SRPN2 has been shown to 
negatively regulate melanization and is able to inhibit CLIPB9 and SRPN2 knockdown 
mosquitoes show spontaneous melanization and a decreased lifespan (An et al., 2011).  If 
SRPN9 were the major regulator of CLIPB9, we would expect to see a phenotype similar to the 
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well characterized SRPN2, yet there was no visible phenotype associated with SRPN9 
knockdown.  This may be explained if SRPN2 is not the physiological regulator of CLIPB9. 
SRPN2 could be a better inhibitor of yet identified proteases involved in the extracellular PO 
activating cascade.  Another explanation is that SRPN2 is expressed highly in An. gambiae 
hemolymph when compared to SRPN9.  If SRPN2 is present in a much higher concentration 
than SRPN9, knockdown of SRPN9 would in effect be rescued by the presence of SRPN2 in the 
hemolymph.  To tease out these specifics, more experiments will have to be done.  For now, the 
key finding in this study is that An. gambiae SRPN9 is an inhibitory SRPN and is able to inhibit 
proteases with trypsin and chymotrypsin-like specifies including known PAP, CLIPB9 in vitro. 
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3.7 Tables 
Table 3.1: SRPN9 commercial protease assays 
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Table 3.2: Inhibition of protease activity by recombinant SRPN9 
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Table 3.3: MS/MS Confirms SRPN9 forms complex with CLIPB9 
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Table 3.4: Primer sequences 
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 3.8 Figure Legends 
 
Figure 3-1: Amino acid sequence alignment of reactive center loops from AgSRPN9 and 
orthologs 
Alignment of An. gambiae SRPN9 reactive center loop with orthologous genes in M. sexta, D.  
melanogaster, Ae. aegypti, C. quinquefasciatus, and Apis mellifera. Canonical Human alpha-1-
antitrypsin in also aligned.  Alignment was performed in “PFAAT" (Bioinformatics, 2007).  
Predicted scissile bond is indicated by red line.  Consensus sequence is beneath conservation 
score in grey. 
 
Figure 3-2: Nucleic acid and deduced amino acid sequence of SRPN9 
SRPN9 nucleic acid sequence and deduced amino acid sequence performed in Vector NTI 
Advance (Invitrogen).  6-His tag is underlined in green.  dsRNA primer sequences are underlined 
in red.  
 
Figure 3-3: Protein purification of recombinant SRPN9 
EZ-Run Protein Gel Staining solution stained 10% SDS gel after (A) Nickel (Ni-NTA) affinity 
chromatography and (B) Q-Sepharose chromatography.  (A) From left to right: Pre-induction 
(PI), Hours post protein induction (hpi) 2, 3, 4.  Soluble protein(S), Insoluble protein (IS), 
Marker (M), Wash 1-3, Elutions 1-3.  Protein was eluted with 300mM NaCl + 250mM imidazole 
pH= 8.0 at 1 ml/min. (B)Protein was run through column containing Q-Sepharose beads washed, 
and eluted at 1ml/min in a 50-500mM pH= 8.0 linear NaCl gradient.  Numbers are elution 
numbers. 
 
Figure 3-4: Survival for SRPN9 depleted mosquitoes  
Percent survival of mosquitoes injected with dsRNA targeting SRPN9 (red), GFP (green), or not 
injected (black). Each graph represents an independent, individual biological replicate. Log rank 
test was performed to compare the curves. A. Χ2=0.2462, df=1, p=0.6197    B. Χ2=0.9640, df=1, 
p=0.3262 
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Figure 3-5: SRPN9 expression after blood meal time course 
Relative expression of SRPN9 after blood meal time course.  Expression was normalized to 
RPS7 nonblood fed control samples were used as calibrator.  Statistical tests performed is 2 way 
ANOVA. Error bars are mean and SEM of three replicates. P =0.0005. 
 
Figure 3-6: Recombinant AgSRPN9 inhibits trypsin-like serine proteases 
SRPN9 protein was incubated with (A) chymotrypsin or (B) trypsin for ten minutes at room 
temperature at 1:1 or 10:1 SRPN:protease molar ratios.   200 µl of 50µM substrate was added 
and absorbance was measured immediately every 30 s for 41 times at 405nm. Bar graphs 
represent residual activity and dot graphs are representative assay of three replicates. Error bars 
are mean and SEM of three biological replicates. 
 
Figure 3-7: SRPN9 inhibition of PO activity in M. sexta hemolymph 
Different amounts of SRPN9 were incubated with M. sexta plasma at room temperature for ten 
minutes. PO was activated by the addition of M. luteus.  Dopamine HCL was added as substrate 
and PO activity was measured every 30 sec, 41 times at 405nm. (A). Representative assay of 
three replicates.  Error bars are mean and SEM. One-way ANOVA, p< 0.0001 Newman Kuels 
post test, (B). Combined protease activity of three biological replicates. Error bars are mean and 
SEM.  All treatments are statistically different (p < 0.05) 
 
Figure 3-8: SRPN9 inhibits and forms complex with CLIPB9   
rSRPN9 was incubated with Factor Xa activated (A) rCLIPB8 or (B) rCLIPB9 at room 
temperature for Ten minutes.  FVR-AMC was used as substrate and FVRase activity was 
measured immediately every 30 sec, 41 times.  Error bars are mean and SEM of three biological. 
(C) Activation of recombinant CLIPB9 and complex formation via Western Blot analysis using 
anti-SRPN9 and anti-CLIPB9 antibodies.  Asterisk indicates complex. 
 
Figure 3-9: High molecular weight band is complex of SRPN9 and CLIPB9 
rSRPN9 (2µg) and rCLIPB9Xa (1µg) were incubated for 10 minutes at room temperature. 
Proteins were then ran on 10% SDS-PAGE as described in Materials and Methods.  Proteins 
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were stained with EZ-Run Protein Gel Staining solution.  The highest molecular band (Asterisk 
indicates complex) was further analyzed by1D NanoLC ESI MS/MS (Table 3.3). 
Figure 3-10: Stoichiometry of inhibition of recombinant SRPN9 to CLIPB9 
rSRPN9 was incubated with Factor Xa activated rCLIPB9 at different molar ratios. FVR-AMC 
was used as substrate and FVRase activity was measured every 30 s for 61 times.  Linear 
regression of the residual FVRase activity was plotted.  Error bars are mean and SEM of three 
technical replicates. 
 
Figure 3-11: Ka of recombinant SRPN9 to CLIPB9 
 (A) 300µM FVR-AMC was added varying concentrations of rSRPN9 (0, 4.3, 8.6, 13, 17.3, 25.9, 
34.5 and 51.8 nM) plus 213nM BSA.  rCLIPB9Xa (2.37pmol) was added. FVRase activity was 
measured every 30s, 50 times.  B.  Linear regression of A. 
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 3.9 Figures 
Figure 3-1: Amino acid sequence alignment of reactive center loops from AgSRPN9 and 
orthologs 
 
 
 
84 
 
Figure 3-2: Nucleic acid and deduced amino acid sequence of SRPN9 
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Figure 3-3: Protein purification of recombinant SRPN9 
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Figure 3-4: SRPN9 depletion does not affect survival 
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Figure 3-5: SRPN9 expression after blood meal time course 
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Figure 3-6: Recombinant AgSRPN9 inhibits trypsin-like serine proteases 
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Figure 3-7: SRPN9 inhibition of PO activity in M. sexta hemolymph 
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Figure 3-8: SRPN9 inhibits and forms complex with CLIPB9 
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Figure 3-9: High molecular weight band is complex of SRPN9 and CLIPB9 
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Figure 3-10: Stoichiometry of inhibition of recombinant SRPN9 to CLIPB9 
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Figure 3-11: Ka of recombinant SRPN9 to CLIPB9 
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Appendix A   
Individual replicates of commercial activity assays for each SRPN:protease combination. 
 
Figure A-1: SRPN9 inhibits Chymotrypsin 
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Figure A-2: SRPN9 inhibits Trypsin 
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Supplemental Figure A-3: SRPN9 inhibits Kallikrein 
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Supplemental Figure A-4: SRPN9 inhibits Plasmin 
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Supplemental Figure A-5: SRPN9 inhibits Thrombin at a 10:1 ratio 
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Supplemental Figure A-6: rSRPN9 does not inhibit Elastase 
 
 
 
101 
 
Supplemental Figure A-7:rSRPN9 does not inhibit Protease K 
 
 
102 
 
Supplemental Figure A-8: rSRPN9 does not inhibit Subtilisin Carlsberg 
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Supplemental Figure B-1: rSRPN7  inhibits Trypsin 
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Supplemental Figure B-2: rSRPN7 inhibits Plasmin 
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Supplemental Figure B-3: rSRPN7 inhibits Kallikrein 
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Supplemental Figure B-4: rSRPN7 does not inhibit Chymotrypsin 
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Supplemental Figure B-5: rSRPN7 does not inhibit thrombin 
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Supplemental Figure B-6: rSRPN7 does not  inhibit Subtilisin Carlsberg 
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Supplemental Figure C-1: rSRPN18 marginally inhibits trypsin  
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Supplemental Figure C-2: rSRPN18 marginally inhibits kallikrein 
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Supplemental Figure C-3: rSRPN18 marginally inhibits plasmin 
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Supplemental Figure C-4: rSRPN18 does not  inhibit Subtilisin Carlsberg 
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Supplemental Figure C-5: rSRPN18 does not  inhibit Protease K 
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Supplemental Figure C-6: rSRPN18 does not  inhibit elastase 
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Supplemental Figure C-7: rSRPN18 does not  inhibit chymotrypsin 
 
 
